Who Owns Invitae?
Invitae is owned by Labcorp Holdings Inc. (NYSE: LH), which acquired the medical genetics company's assets for $239 million in August 2024 after Invitae filed for Chapter 11 bankruptcy. Founded in San Francisco in 2010, the brand provides genetic testing for hereditary cancer, rare diseases, and reproductive health through Labcorp's diagnostics network.
Parent Company
Acquired
2024
Status
Publicly Traded
Headquarters
Invitae Timeline
United StatesOfficial Website
Who Owns Invitae?
- Parent Company: Labcorp Holdings Inc.
- Ownership Type: Subsidiary
- Acquisition Year: 2024
- Company Type: Publicly Traded
- Stock Ticker: NYSE: LH
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Invitae | Labcorp Holdings Inc. | Subsidiary |
Where to Buy
Disclosure: We may earn commission from purchases
Invitae on AmazonAdvertisement
History of Invitae
- Founded: 2010
- Founders: Sean George, Randy Scott
- Acquired by Labcorp Holdings Inc.: 2024
Invitae was founded in San Francisco in 2010, incubated inside Genomic Health by executives including Sean George and Randy Scott, and spun out as an independent company in 2012. Its founding idea was to make comprehensive genetic testing cheap enough for routine medical use rather than a specialist luxury.
The company went public in 2015 and grew aggressively, acquiring a string of smaller genetics businesses including Good Start Genetics, CombiMatrix, Genosity, and the consumer health data company Ciitizen. Revenue scaled rapidly, but profitability never arrived, and a heavy debt load plus a pivot into data services proved costly.
By 2023 Invitae was shrinking to survive. It filed for Chapter 11 bankruptcy in February 2024, and in April Labcorp agreed to buy the core business for $239 million. The sale closed August 5, 2024, and the old public shell wound down under a confirmed plan.
Under Labcorp, the brand kept its identity and test catalog: hereditary cancer panels, rare disease diagnostics, reproductive carrier screening, and genetic counseling services, now distributed through Labcorp's payer relationships and patient service centers.
Advertisement
About Labcorp Holdings Inc.
What does Labcorp own?
Labcorp owns the Labcorp diagnostics network of more than 2,000 patient service centers, the Labcorp OnDemand consumer platform, the Invitae genetic testing business, Ovia Health, and its Biopharma Laboratory Services operations serving drug developers.
Is Labcorp publicly traded?
Yes. Labcorp trades on the New York Stock Exchange under ticker LH and is a member of the S&P 500.
Who founded Labcorp?
Labcorp was formed in 1995 through the merger of National Health Laboratories and Roche Biomedical Laboratories. The Burlington predecessor, Biomedical Laboratories, was founded in 1969 by brothers James, Thomas, and John Powell.
Where is Labcorp headquartered?
Labcorp is headquartered in Burlington, North Carolina, USA.
Advertisement
How many brands does Labcorp own?
Its principal brands are Labcorp, Labcorp OnDemand, Invitae, and Ovia Health, alongside enterprise brands serving pharmaceutical clients.
Who owns Labcorp?
Labcorp is an independent public company owned by its shareholders, predominantly institutional investors. No parent company controls it.
Did Labcorp buy Invitae?
Yes. Labcorp acquired select assets of Invitae for $239 million in August 2024 after Invitae filed for Chapter 11 bankruptcy, adding its genetic testing portfolio for oncology and rare diseases.
- Founded: 1978
- Headquarters: Burlington, North Carolina, USA
- Company Type: Publicly Traded
- Stock: NYSE: LH
- Revenue: $13.95 billion (FY2025)
- Employees: Approximately 70,000
Where Is Invitae Made / Based?
- Headquarters: San Francisco, California, USA
Invitae Categories & Tags
Invitae Recalls & Controversies
Invitae's defining event was its own collapse. Years of acquisition-fueled growth without profitability ended in a February 2024 Chapter 11 filing, with the company wound down and its assets sold to Labcorp. Shareholders were effectively wiped out.
Advertisement
Before the collapse, the company faced a 2023 securities class action and an investigation into whether executives misled investors about its finances, settled as part of the bankruptcy process.
Operationally, a 2021 incident in which some Invitae test results required re-contacting patients over a variant classification issue drew industry attention to genetic test interpretation quality. The matter was resolved through revised reporting.
Brands Owned by Labcorp Holdings Inc.
Advertisement
Invitae Ownership: Pros & Cons
Advantages
- +Labcorp's payer contracts expand insurance coverage for its tests
- +Access to 2,000-plus patient service centers for specimen collection
- +Stable parent removes the financing risk that collapsed the old company
- +Combined test catalog exceeds 6,500 tests across the brands
- +Labcorp's clinical trial relationships add pharma revenue channels
Considerations
- -Bankruptcy history damaged some provider and investor trust
- -Integration may reduce the brand's independent product development speed
- -Genetic data handling carries HIPAA and privacy exposure
- -Specialist competitors like Natera and GeneDx keep advancing
- -Brand equity now depends on Labcorp's service quality as much as its own
Frequently Asked Questions About Invitae
Advertisement
Sources & Further Reading
Competitors to Invitae
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Labcorp | USA | 1995 | Mass market | United states | All Genders | |
| Mckesson | USA | 1994 | Mass market | United states | All-ages | |
| Quest Diagnostics | Finland | 2012 | Mass market | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsLabcorp
Owned by Labcorp Holdings Inc.
Diagnostic testing brand of Labcorp Holdings Inc., running one of the world's largest clinical laboratory networks with over 2,000 patient service centers.
diagnosticslaboratory-testinghealthcare
Healthcare PharmaceuticalsBiologics by McKesson
Owned by McKesson Corporation
Independent specialty pharmacy providing personalized patient care for oncology and rare disease treatments owned by McKesson Corporation.
specialty-pharmacyoncologyrare-disease
Healthcare PharmaceuticalsBlueprint Genetics
Owned by Quest Diagnostics Incorporated
The genetic testing subsidiary of Quest Diagnostics, specializing in rare inherited disease diagnostics.
genetic-testingrare-diseasegenomics
Competitive Analysis
Market Positioning: Invitae competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Invitae
Looking for brands with different ownership structures? These similar brands are not owned by Labcorp Holdings Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsAvaility
Owned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
healthcare-technologyclearinghouseclaims-processing
Privately Owned
Availity is privately owned, unlike Invitae which is under a publicly traded parent company.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Invitae which is under a publicly traded parent company.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike Invitae which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoots
Owned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
pharmacyhealth-beautyuk-retail
Privately Owned
Boots is privately owned, unlike Invitae which is under a publicly traded parent company.
Healthcare PharmaceuticalsDuane Reade
Owned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
pharmacydrugstorenew-york
Privately Owned
Duane Reade is privately owned, unlike Invitae which is under a publicly traded parent company.
Healthcare PharmaceuticalsMD Clarity
Owned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
healthcare-technologyrevenue-cyclecontract-management
Privately Owned
MD Clarity is privately owned, unlike Invitae which is under a publicly traded parent company.
Labcorp Holdings Inc. Stock Information
Advertisement
Jobs at Labcorp Holdings Inc.
Latest News About Invitae
Advertisement
Related Articles About Invitae
View more articles
News & Updates
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Who Brands StaffNov 6, 2026
Ipo RoundupIpoStock Market
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Rivalry
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Who Brands StaffOct 23, 2026
DuracellEnergizerRivalry
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth